English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Research links childhood factors to adult health conditions via later menarche timing
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Lilly reports early efficacy for blood cancer drug from Ajax acquisition
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Researchers examine ibogaine’s matrix pharmacology and safety challenges in new study
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

FDA clears noribogaine for U.S. trials amid ongoing safety concerns and regulatory caution
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Amylyx advances new therapies after withdrawal of ALS drug Relyvrio
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Study finds link between problematic social media use and memory issues in young adults
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Study links long daily naps to higher liver disease risk in type 2 diabetes patients
+ Pharmaceuticals
Patient Daily | Jun 15, 2026

Elicio to proceed with Phase 3 trial after mid-stage pancreatic cancer study misses endpoint

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation